Selected research
Market Analysis & Forecast
Global IVIg Liquid Market Analysis and Forecast 2026-2032
Market perspective
The global IVIg Liquid market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for IVIg Liquid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for IVIg Liquid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for IVIg Liquid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for IVIg Liquid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of IVIg Liquid include Takeda, Sichuan Yuanda Shuyang, Shanghai RAAS, Hualan Bio, Octapharma, LFB Group, Kedrion, Grifols and CSL, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for IVIg Liquid, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of IVIg Liquid, also provides the sales of main regions and countries. Of the upcoming market potential for IVIg Liquid, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the IVIg Liquid sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global IVIg Liquid market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for IVIg Liquid sales, projected growth trends, production technology, application and end-user industry.
IVIg Liquid Segment by Company
Takeda
Sichuan Yuanda Shuyang
Shanghai RAAS
Hualan Bio
Octapharma
LFB Group
Kedrion
Grifols
CSL
CNBG
CBPO
BPL
Biotest
IVIg Liquid Segment by Type
50ml
25ml
IVIg Liquid Segment by Application
Autoimmune Disease
Immunodeficiency
Acute Infection
IVIg Liquid Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IVIg Liquid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of IVIg Liquid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IVIg Liquid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of IVIg Liquid in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of IVIg Liquid manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, IVIg Liquid sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 50ml
- 25ml
Applications
- Autoimmune Disease
- Immunodeficiency
- Acute Infection
Companies covered
- Takeda
- Sichuan Yuanda Shuyang
- Shanghai RAAS
- Hualan Bio
- Octapharma
- LFB Group
- Kedrion
- Grifols
- CSL
- CNBG
- CBPO
- BPL
- Biotest
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 IVIg Liquid Market by Type
- 1.2.1 Global IVIg Liquid Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 50ml
- 1.2.3 25ml
- 1.3 IVIg Liquid Market by Application
- 1.3.1 Global IVIg Liquid Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Autoimmune Disease
- 1.3.3 Immunodeficiency
- 1.3.4 Acute Infection
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 IVIg Liquid Market Dynamics
- 2.1 IVIg Liquid Industry Trends
- 2.2 IVIg Liquid Industry Drivers
- 2.3 IVIg Liquid Industry Opportunities and Challenges
- 2.4 IVIg Liquid Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global IVIg Liquid Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global IVIg Liquid Revenue by Region
- 3.2.1 Global IVIg Liquid Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global IVIg Liquid Revenue by Region (2021-2026)
- 3.2.3 Global IVIg Liquid Revenue by Region (2027-2032)
- 3.2.4 Global IVIg Liquid Revenue Market Share by Region (2021-2032)
- 3.3 Global IVIg Liquid Sales Estimates and Forecasts 2021-2032
- 3.4 Global IVIg Liquid Sales by Region
- 3.4.1 Global IVIg Liquid Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global IVIg Liquid Sales by Region (2021-2026)
- 3.4.3 Global IVIg Liquid Sales by Region (2027-2032)
- 3.4.4 Global IVIg Liquid Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global IVIg Liquid Revenue by Manufacturers
- 4.1.1 Global IVIg Liquid Revenue by Manufacturers (2021-2026)
- 4.1.2 Global IVIg Liquid Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global IVIg Liquid Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global IVIg Liquid Sales by Manufacturers
- 4.2.1 Global IVIg Liquid Sales by Manufacturers (2021-2026)
- 4.2.2 Global IVIg Liquid Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global IVIg Liquid Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global IVIg Liquid Sales Price by Manufacturers (2021-2026)
- 4.4 Global IVIg Liquid Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global IVIg Liquid Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global IVIg Liquid Manufacturers, Product Type & Application
- 4.7 Global IVIg Liquid Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global IVIg Liquid Market CR5 and HHI
- 4.8.2 2025 IVIg Liquid Tier 1, Tier 2, and Tier 3
5 IVIg Liquid Market by Type
- 5.1 Global IVIg Liquid Revenue by Type
- 5.1.1 Global IVIg Liquid Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global IVIg Liquid Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global IVIg Liquid Revenue Market Share by Type (2021-2032)
- 5.2 Global IVIg Liquid Sales by Type
- 5.2.1 Global IVIg Liquid Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global IVIg Liquid Sales by Type (2021-2032) & (k units)
- 5.2.3 Global IVIg Liquid Sales Market Share by Type (2021-2032)
- 5.3 Global IVIg Liquid Price by Type
6 IVIg Liquid Market by Application
- 6.1 Global IVIg Liquid Revenue by Application
- 6.1.1 Global IVIg Liquid Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global IVIg Liquid Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global IVIg Liquid Revenue Market Share by Application (2021-2032)
- 6.2 Global IVIg Liquid Sales by Application
- 6.2.1 Global IVIg Liquid Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global IVIg Liquid Sales by Application (2021-2032) & (k units)
- 6.2.3 Global IVIg Liquid Sales Market Share by Application (2021-2032)
- 6.3 Global IVIg Liquid Price by Application
7 Company Profiles
- 7.1 Takeda
- 7.1.1 Takeda Company Information
- 7.1.2 Takeda Business Overview
- 7.1.3 Takeda IVIg Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Takeda IVIg Liquid Product Portfolio
- 7.1.5 Takeda Recent Developments
- 7.2 Sichuan Yuanda Shuyang
- 7.2.1 Sichuan Yuanda Shuyang Company Information
- 7.2.2 Sichuan Yuanda Shuyang Business Overview
- 7.2.3 Sichuan Yuanda Shuyang IVIg Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Sichuan Yuanda Shuyang IVIg Liquid Product Portfolio
- 7.2.5 Sichuan Yuanda Shuyang Recent Developments
- 7.3 Shanghai RAAS
- 7.3.1 Shanghai RAAS Company Information
- 7.3.2 Shanghai RAAS Business Overview
- 7.3.3 Shanghai RAAS IVIg Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Shanghai RAAS IVIg Liquid Product Portfolio
- 7.3.5 Shanghai RAAS Recent Developments
- 7.4 Hualan Bio
- 7.4.1 Hualan Bio Company Information
- 7.4.2 Hualan Bio Business Overview
- 7.4.3 Hualan Bio IVIg Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Hualan Bio IVIg Liquid Product Portfolio
- 7.4.5 Hualan Bio Recent Developments
- 7.5 Octapharma
- 7.5.1 Octapharma Company Information
- 7.5.2 Octapharma Business Overview
- 7.5.3 Octapharma IVIg Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Octapharma IVIg Liquid Product Portfolio
- 7.5.5 Octapharma Recent Developments
- 7.6 LFB Group
- 7.6.1 LFB Group Company Information
- 7.6.2 LFB Group Business Overview
- 7.6.3 LFB Group IVIg Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 LFB Group IVIg Liquid Product Portfolio
- 7.6.5 LFB Group Recent Developments
- 7.7 Kedrion
- 7.7.1 Kedrion Company Information
- 7.7.2 Kedrion Business Overview
- 7.7.3 Kedrion IVIg Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Kedrion IVIg Liquid Product Portfolio
- 7.7.5 Kedrion Recent Developments
- 7.8 Grifols
- 7.8.1 Grifols Company Information
- 7.8.2 Grifols Business Overview
- 7.8.3 Grifols IVIg Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Grifols IVIg Liquid Product Portfolio
- 7.8.5 Grifols Recent Developments
- 7.9 CSL
- 7.9.1 CSL Company Information
- 7.9.2 CSL Business Overview
- 7.9.3 CSL IVIg Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 CSL IVIg Liquid Product Portfolio
- 7.9.5 CSL Recent Developments
- 7.10 CNBG
- 7.10.1 CNBG Company Information
- 7.10.2 CNBG Business Overview
- 7.10.3 CNBG IVIg Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 CNBG IVIg Liquid Product Portfolio
- 7.10.5 CNBG Recent Developments
- 7.11 CBPO
- 7.11.1 CBPO Company Information
- 7.11.2 CBPO Business Overview
- 7.11.3 CBPO IVIg Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 CBPO IVIg Liquid Product Portfolio
- 7.11.5 CBPO Recent Developments
- 7.12 BPL
- 7.12.1 BPL Company Information
- 7.12.2 BPL Business Overview
- 7.12.3 BPL IVIg Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 BPL IVIg Liquid Product Portfolio
- 7.12.5 BPL Recent Developments
- 7.13 Biotest
- 7.13.1 Biotest Company Information
- 7.13.2 Biotest Business Overview
- 7.13.3 Biotest IVIg Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 Biotest IVIg Liquid Product Portfolio
- 7.13.5 Biotest Recent Developments
8 North America
- 8.1 North America IVIg Liquid Market Size by Type
- 8.1.1 North America IVIg Liquid Revenue by Type (2021-2032)
- 8.1.2 North America IVIg Liquid Sales by Type (2021-2032)
- 8.1.3 North America IVIg Liquid Price by Type (2021-2032)
- 8.2 North America IVIg Liquid Market Size by Application
- 8.2.1 North America IVIg Liquid Revenue by Application (2021-2032)
- 8.2.2 North America IVIg Liquid Sales by Application (2021-2032)
- 8.2.3 North America IVIg Liquid Price by Application (2021-2032)
- 8.3 North America IVIg Liquid Market Size by Country
- 8.3.1 North America IVIg Liquid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America IVIg Liquid Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America IVIg Liquid Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe IVIg Liquid Market Size by Type
- 9.1.1 Europe IVIg Liquid Revenue by Type (2021-2032)
- 9.1.2 Europe IVIg Liquid Sales by Type (2021-2032)
- 9.1.3 Europe IVIg Liquid Price by Type (2021-2032)
- 9.2 Europe IVIg Liquid Market Size by Application
- 9.2.1 Europe IVIg Liquid Revenue by Application (2021-2032)
- 9.2.2 Europe IVIg Liquid Sales by Application (2021-2032)
- 9.2.3 Europe IVIg Liquid Price by Application (2021-2032)
- 9.3 Europe IVIg Liquid Market Size by Country
- 9.3.1 Europe IVIg Liquid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe IVIg Liquid Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe IVIg Liquid Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China IVIg Liquid Market Size by Type
- 10.1.1 China IVIg Liquid Revenue by Type (2021-2032)
- 10.1.2 China IVIg Liquid Sales by Type (2021-2032)
- 10.1.3 China IVIg Liquid Price by Type (2021-2032)
- 10.2 China IVIg Liquid Market Size by Application
- 10.2.1 China IVIg Liquid Revenue by Application (2021-2032)
- 10.2.2 China IVIg Liquid Sales by Application (2021-2032)
- 10.2.3 China IVIg Liquid Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia IVIg Liquid Market Size by Type
- 11.1.1 Asia IVIg Liquid Revenue by Type (2021-2032)
- 11.1.2 Asia IVIg Liquid Sales by Type (2021-2032)
- 11.1.3 Asia IVIg Liquid Price by Type (2021-2032)
- 11.2 Asia IVIg Liquid Market Size by Application
- 11.2.1 Asia IVIg Liquid Revenue by Application (2021-2032)
- 11.2.2 Asia IVIg Liquid Sales by Application (2021-2032)
- 11.2.3 Asia IVIg Liquid Price by Application (2021-2032)
- 11.3 Asia IVIg Liquid Market Size by Country
- 11.3.1 Asia IVIg Liquid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia IVIg Liquid Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia IVIg Liquid Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA IVIg Liquid Market Size by Type
- 12.1.1 SAMEA IVIg Liquid Revenue by Type (2021-2032)
- 12.1.2 SAMEA IVIg Liquid Sales by Type (2021-2032)
- 12.1.3 SAMEA IVIg Liquid Price by Type (2021-2032)
- 12.2 SAMEA IVIg Liquid Market Size by Application
- 12.2.1 SAMEA IVIg Liquid Revenue by Application (2021-2032)
- 12.2.2 SAMEA IVIg Liquid Sales by Application (2021-2032)
- 12.2.3 SAMEA IVIg Liquid Price by Application (2021-2032)
- 12.3 SAMEA IVIg Liquid Market Size by Country
- 12.3.1 SAMEA IVIg Liquid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA IVIg Liquid Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA IVIg Liquid Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 IVIg Liquid Value Chain Analysis
- 13.1.1 IVIg Liquid Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 IVIg Liquid Production Mode & Process
- 13.2 IVIg Liquid Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 IVIg Liquid Distributors
- 13.2.3 IVIg Liquid Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst